BCMA Antigen binding proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10220090
APP PUB NO 20170165373A1
SERIAL NO

14967167

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN INCONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armitage, Richard J Bainbridge Island, US 41 808
Blake, Michelle Arlington, US 3 90
Fanslow,, III William C Normandy Park, US 14 114
Kannan, Gunasekaran Daly City, US 62 1211
O'Neill, Jason Charles Brier, US 7 93
Tometsko, Mark Edward Seattle, US 3 90
Xu, Jiangchun San Diego, US 103 1050

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 5, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 5, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00